Markets

Corona Remedies IPO Day 1: Check GMP, subscription status, key dates, review and other details - should you subscribe?

December 8, 2025

Corona Remedies IPO Day 1: The initial public offering (IPO) of pharma company Corona Remedies opened for public subscription on December 8 and will close on Wednesday, December 10. The price band for the Corona Remedies IPO has been set between ₹1,008 and ₹1,062 per equity share. Retail investors can apply for a minimum of one lot of 14 shares, requiring an investment of ₹14,868 at the upper end.

Credit: Livemint

Key Highlights

Bids can be placed in multiples of 14 shares thereafter.
The ₹655.37 crore issue is entirely an offer for sale of 0.62 crore shares with no fresh issuance.
Existing shareholders, including Sepia Investments, Anchor Partners and Sage Investment Trust, will divest part of their stake.
Since the IPO is a pure OFS, the company will not receive any proceeds.
The basis of allotment for the Corona Remedies IPO is expected to be finalised on Thursday, December 11.

Sources

Corona Remedies IPO Day 1: Check GMP, subscription status, key dates, review and other details - should you subscribe?

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

Corona Remedies IPO Day 1: Check GMP, subscription status, key dates, review and other details - should you subscribe?

Key Highlights

Sources

Related Stories

2 Warren Buffett Dividend Stocks to Buy With $1,000

Morning Bid: Seoul-sapping selloff

Dow Jones Futures Rise On Iran Outreach Report; Trump Makes This Pledge